JP2018524019A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018524019A5 JP2018524019A5 JP2018515195A JP2018515195A JP2018524019A5 JP 2018524019 A5 JP2018524019 A5 JP 2018524019A5 JP 2018515195 A JP2018515195 A JP 2018515195A JP 2018515195 A JP2018515195 A JP 2018515195A JP 2018524019 A5 JP2018524019 A5 JP 2018524019A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- molecular weight
- polypeptide
- isolated
- high molecular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021158128A JP7404320B2 (ja) | 2015-06-05 | 2021-09-28 | 線維症の治療において使用するためのエンドスタチン断片およびバリアント |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562171889P | 2015-06-05 | 2015-06-05 | |
| US62/171,889 | 2015-06-05 | ||
| US201562257607P | 2015-11-19 | 2015-11-19 | |
| US62/257,607 | 2015-11-19 | ||
| PCT/US2016/035858 WO2016197018A1 (en) | 2015-06-05 | 2016-06-03 | Endostatin fragments and variants for use in treating fibrosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021158128A Division JP7404320B2 (ja) | 2015-06-05 | 2021-09-28 | 線維症の治療において使用するためのエンドスタチン断片およびバリアント |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018524019A JP2018524019A (ja) | 2018-08-30 |
| JP2018524019A5 true JP2018524019A5 (cg-RX-API-DMAC7.html) | 2019-07-04 |
| JP6952685B2 JP6952685B2 (ja) | 2021-10-20 |
Family
ID=56236074
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018515195A Expired - Fee Related JP6952685B2 (ja) | 2015-06-05 | 2016-06-03 | 線維症の治療において使用するためのエンドスタチン断片およびバリアント |
| JP2021158128A Active JP7404320B2 (ja) | 2015-06-05 | 2021-09-28 | 線維症の治療において使用するためのエンドスタチン断片およびバリアント |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021158128A Active JP7404320B2 (ja) | 2015-06-05 | 2021-09-28 | 線維症の治療において使用するためのエンドスタチン断片およびバリアント |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10844392B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3303383A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6952685B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20180033499A (cg-RX-API-DMAC7.html) |
| CN (2) | CN107849117B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2016270428B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112017026209A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2988299C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016197018A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201708223B (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016197018A1 (en) * | 2015-06-05 | 2016-12-08 | Ibio, Inc. | Endostatin fragments and variants for use in treating fibrosis |
| AU2019338416A1 (en) * | 2018-09-14 | 2021-04-29 | Akso Biopharmaceutical, Inc. | sPD-1 variant - Fc fusion proteins |
| WO2021007094A1 (en) * | 2019-07-10 | 2021-01-14 | Musc Foundation For Research Development | Endostatin peptides for the treatment of tumors, fibrosis and acute lung injury |
| US12454551B2 (en) * | 2019-07-31 | 2025-10-28 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Peptides as inhibitors of fibrotic matrix accumulation |
| JP7493945B2 (ja) * | 2020-01-28 | 2024-06-03 | ポーラ化成工業株式会社 | 培養組織の観察方法、培養方法、評価方法及び培養器具 |
| WO2022006601A1 (en) * | 2020-07-02 | 2022-01-06 | Northwestern University | Human recombinant ace2-fc mutants that decouple anti-sars-cov-2 activity from cardiovascular effects |
| US20250195673A1 (en) * | 2020-11-30 | 2025-06-19 | Fred Hutchinson Cancer Center | Compositions and methods for selective depletion of target molecules |
| EP4392056A4 (en) * | 2021-09-07 | 2025-12-24 | Musc Found For Res Dev | Endostatin peptides for the treatment of tumors, fibrosis, and acute lung injury |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US750375A (en) | 1904-01-26 | Potato-digger | ||
| US3854480A (en) | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
| US3832253A (en) | 1973-03-21 | 1974-08-27 | Baxter Laboratories Inc | Method of making an inflatable balloon catheter |
| US4667014A (en) | 1983-03-07 | 1987-05-19 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists |
| US7045313B1 (en) | 1982-11-30 | 2006-05-16 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA |
| US4452775A (en) | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
| IT1164225B (it) | 1983-05-13 | 1987-04-08 | Anic Spa | Analoghi retro-invertiti del pentapeptide potenziante la bradichina bpp5a e metodi per la loro preparazione |
| CA1200416A (en) | 1983-05-13 | 1986-02-11 | Societe Des Produits Nestle S.A. | Food process |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US5091309A (en) | 1986-01-16 | 1992-02-25 | Washington University | Sindbis virus vectors |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| US5093258A (en) | 1988-08-26 | 1992-03-03 | Therion Biologics Corporation | Recombinant fowlpox virus and recombination vector |
| US5217879A (en) | 1989-01-12 | 1993-06-08 | Washington University | Infectious Sindbis virus vectors |
| US6406697B1 (en) | 1989-02-23 | 2002-06-18 | Genentech, Inc. | Hybrid immunoglobulins |
| US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
| ES2133271T3 (es) | 1989-07-06 | 1999-09-16 | Univ California | Receptores para factores de crecimiento de fibroblastos. |
| JPH04167172A (ja) | 1990-10-31 | 1992-06-15 | Nec Corp | ベクトルプロセッサ |
| US5756671A (en) | 1994-06-02 | 1998-05-26 | Mitotix, Inc. | CDC37 cell-cycle regulatory protein, and uses related thereto |
| US6080560A (en) * | 1994-07-25 | 2000-06-27 | Monsanto Company | Method for producing antibodies in plant cells |
| US5541087A (en) | 1994-09-14 | 1996-07-30 | Fuji Immunopharmaceuticals Corporation | Expression and export technology of proteins as immunofusins |
| US6165460A (en) | 1995-07-10 | 2000-12-26 | Therion Biologics Corporation | Generation of immune responses to prostate-specific antigen (PSA) |
| US5925351A (en) | 1995-07-21 | 1999-07-20 | Biogen, Inc. | Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| DE19535939A1 (de) | 1995-09-27 | 1997-04-03 | Agfa Gevaert Ag | Fotografisches Material |
| IL136667A0 (en) | 1997-12-08 | 2001-06-14 | Beth Israel Hospital | Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| EP1067956B1 (en) | 1998-04-03 | 2007-03-14 | University Of Iowa Research Foundation | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| WO1999062944A2 (en) * | 1998-06-03 | 1999-12-09 | The Children's Medical Center Corporation | Protein oligomer compositions comprising endostatin protein and methods of using the same |
| US6399075B1 (en) | 1998-07-02 | 2002-06-04 | President And Fellows Of Harvard College | Compositions and methods for treating Papillomavirus-infected cells |
| WO2000046350A1 (en) | 1999-02-05 | 2000-08-10 | Thomas Jefferson University | Production of biomedical peptides and proteins in plants using transcomplementation systems |
| US6656728B1 (en) | 1999-02-08 | 2003-12-02 | Chiron Corporation | Fibroblast growth factor receptor-immunoglobulin fusion |
| US7692063B2 (en) * | 2002-11-12 | 2010-04-06 | Ibio, Inc. | Production of foreign nucleic acids and polypeptides in sprout systems |
| ES2531125T3 (es) | 2003-02-03 | 2015-03-10 | Ibio Inc | Sistema para la expresión de genes en plantas |
| US20060024272A1 (en) * | 2004-07-29 | 2006-02-02 | Large Scale Biology Corporation | C-terminally truncated interferon |
| JP2010531666A (ja) * | 2007-06-26 | 2010-09-30 | ユニバーシティ オブ マイアミ | 抗体−エンドスタチン融合タンパク質及びそのバリアント |
| WO2011050311A1 (en) | 2009-10-22 | 2011-04-28 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Use of endostatin peptides for the treatment of fibrosis |
| BR112014001268A2 (pt) * | 2011-07-19 | 2017-02-21 | Thrasos Innovation Inc | peptídeos antifibróticos e seu uso em métodos para tratamento de doenças e distúrbios caracterizados por fibrose |
| WO2016197018A1 (en) | 2015-06-05 | 2016-12-08 | Ibio, Inc. | Endostatin fragments and variants for use in treating fibrosis |
-
2016
- 2016-06-03 WO PCT/US2016/035858 patent/WO2016197018A1/en not_active Ceased
- 2016-06-03 CN CN201680044858.5A patent/CN107849117B/zh active Active
- 2016-06-03 EP EP16732386.4A patent/EP3303383A1/en not_active Withdrawn
- 2016-06-03 JP JP2018515195A patent/JP6952685B2/ja not_active Expired - Fee Related
- 2016-06-03 CN CN202210968572.3A patent/CN115925878A/zh active Pending
- 2016-06-03 US US15/579,690 patent/US10844392B2/en not_active Expired - Fee Related
- 2016-06-03 AU AU2016270428A patent/AU2016270428B2/en not_active Ceased
- 2016-06-03 CA CA2988299A patent/CA2988299C/en active Active
- 2016-06-03 BR BR112017026209A patent/BR112017026209A2/pt not_active Application Discontinuation
- 2016-06-03 KR KR1020187000354A patent/KR20180033499A/ko not_active Ceased
-
2017
- 2017-12-04 ZA ZA2017/08223A patent/ZA201708223B/en unknown
-
2020
- 2020-11-09 US US17/092,539 patent/US11912755B2/en active Active
-
2021
- 2021-02-05 AU AU2021200765A patent/AU2021200765B2/en not_active Ceased
- 2021-09-28 JP JP2021158128A patent/JP7404320B2/ja active Active